"The state of the psychedelic industry" at Horizons 2024

Recorded live at the 16th annual Horizons: Perspectives on Psychedelic conference on Thursday, May 9, 2024 at the New York Academy of Medicine in New York City

“The state of the psychedelic industry”

featuring:


Dan Grossman, PhD

In our opening session for the third annual Psychedelic Business Forum, Dan Grossman, former Managing Director and Senior Partner of the Boston Consulting Group's healthcare practice, will share his view of the state of the psychedelic industry. 

In addition to his history as a healthcare industry analyst and consultant focused on biopharmaceuticals R&D and commercialization, Dan current serves as Head of Field Building for the Psychedelic Science Funders Collaborative (PSFC) and as a board member and impact advisory committee member for Lykos Therapeutics.